Key Highlights: Implications: Sanofi’s Hyderabad bet signals all-in pharma offshoring, vacuuming up AI/data talent that smaller players can’t touch while crushi...
Key Highlights: Implications: India’s GATINN catapults Servier into SPC dominance, crushing fragmented chronic therapy rivals while exploding patient compliance across emerging marke...
Key Highlights: Implications: Imfinzi storms endometrial cancer protocols, giving oncologists a potent immunotherapy combo that leapfrogs chemo-only standards. AstraZeneca doubles do...
Key Highlights: Implications: This partnership accelerates peptide therapy access in high-growth markets, challenging incumbents like Sun Pharma in India’s $500M+ peptide segment whi...
Key Highlights: Implications: Durvalumab storms earlier gastric cancer treatment, snatching share from chemo-only protocols as oncologists embrace immunotherapy combo superiority.&nb...
Key Highlights: Implications: Quality failures erode trust in high-volume generics, handing innovator brands a compliance advantage as hospitals pivot to verified suppliers. Tie...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Latest Developments in Pharma Talent and Innovation India’s pharmaceutical industry has long been recognized for its manufacturing capabilities, particularly in the generics sector. However, in ...
Latest Developments in Peptide-Based Medicines Peptide-based drugs are gaining significant attention in the global pharmaceutical industry due to their ability to target specific biological path...
Latest Developments in Pharma Partnerships and Acquisitions India’s pharmaceutical industry has evolved into one of the most dynamic and globally integrated sectors in healthcare. As companies s...
